I use “big” and sometimes not so big data to accelerate research and improve outcomes for cancer patients. In May 2017, I joined Flatiron Health, a healthcare technology company dedicated to improving lives by learning from the experience of every cancer patient, not just the minority who enroll in clinical trials. Although academia is no longer my primary home, I maintain an affiliate faculty position at UW and have the pleasure to continue mentoring students and serving on several dissertation committees.I earned my masters in public health from Columbia University and began my career as a biostatistician at Memorial Sloan Kettering Cancer Center. In 2011, after 4 years at MSKCC, I moved to Seattle to embark on a PhD at the University of Washington. My dissertation, which was independently funded by AHRQ and the NSF, involved developing statistical and decision analytic methods to estimate the expected risk and return for publicly funded cancer clinical trials and thereby improve the efficiency of limited public investments in cancer research. After completing my PhD in 2014, I began an AHRQ-funded K12 fellowship at Group Health Research Institute and the Fred Hutchinson Cancer Research Center and focused my research on the economic and policy issues impacting investments in cancer clinical trials, particularly from the pharmaceutical industry. Now at Flatiron Health, my research is focused on developing methods to use real-world data to improve the efficiency of cancer clinical trials and thereby accelerate cancer research and improve patient care.